Benign Dermal Neoplasm

subtype

Identifier: CI-CAN-00000496
Entity page: /cancer/benign-dermal-neoplasm ↗
Edges: 21

Neighbours: 6 drugs15 trials
Drawn: 21 of 21 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Benign Dermal Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived6 of 6
→ investigated in trials for	Sirolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Benign Dermal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Mercaptopurinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants

Benign Dermal Neoplasm studied in …STUDIED_INderived15 of 15show fewer
→ studied in	NCT00050752recruiting Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer · condition mapped ALIAS · 15 trials mapped (5 active)	—	—	Skin Leiomyoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07716735Phase 1 · not yet recruiting Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer · condition mapped ONTOLOGY_EXACT · 15 trials mapped (5 active)	—	—	Skin Leiomyoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07102394Phase 1 · recruiting Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1 · condition mapped ALIAS · 15 trials mapped (5 active)	—	—	Skin Neurofibroma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06159166Phase 1/Phase 2 · recruiting Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF). · condition mapped ALIAS · 15 trials mapped (5 active)	—	—	Skin Neurofibroma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05005845Phase 2 · completed NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) · condition mapped ALIAS · 15 trials mapped (5 active)	—	—	Skin Neurofibroma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00975819Phase 2 · completed Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies · condition mapped ALIAS · 15 trials mapped (5 active)	—	—	Tufted Hemangioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05581511active not recruiting Natural History Study of Cutaneous Neurofibromas in People With NF1 · condition mapped ALIAS · 15 trials mapped (5 active)	—	—	Skin Neurofibroma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04730583Phase 1 · completed Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas · condition mapped ALIAS · 15 trials mapped (5 active)	—	—	Skin Neurofibroma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05438290Phase 1 · completed DPCP to Treat Cutaneous Neurofibromas Associated With NF1 · condition mapped ALIAS · 15 trials mapped (5 active)	—	—	Skin Neurofibroma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02839720Phase 2 · completed Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma · condition mapped ALIAS · 15 trials mapped (5 active)	—	—	Skin Neurofibroma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02110069Phase 2 · terminated A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors · condition mapped ALIAS · 15 trials mapped (5 active)	—	—	Tufted Hemangioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05534854unknown Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes · condition mapped ALIAS · 15 trials mapped (5 active)	—	—	Skin Leiomyoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00540566completed Optical Biopsy of Human Skin in Conjunction With Laser Treatment · condition mapped ALIAS · 15 trials mapped (5 active)	—	—	Skin Fibrous Histiocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04435665Phase 2 · completed NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) · condition mapped ALIAS · 15 trials mapped (5 active)	—	—	Skin Neurofibroma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03090971Phase 2 · completed Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1 · condition mapped ALIAS · 15 trials mapped (5 active)	—	—	Skin Neurofibroma	1	Observed	clinicaltrials	graph →

Benign Dermal Neoplasm studied in …STUDIED_INderived15 of 15show fewer

→ studied in

NCT00050752recruiting

Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer · condition mapped ALIAS · 15 trials mapped (5 active)

—

Skin Leiomyoma

Observed

Radial view

Every edge, grouped by relationship

Strongest chains